Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:22 |
|---|---|
| Enthalten in: |
Drugs in R & D - 22(2022), 3 vom: 22. Aug., Seite 253-253 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Vella, Venanzio [VerfasserIn] |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| Anmerkungen: |
© GSK 2022 |
|---|
| doi: |
10.1007/s40268-022-00395-2 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC207945725X |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC207945725X | ||
| 003 | DE-627 | ||
| 005 | 20230507234639.0 | ||
| 007 | tu | ||
| 008 | 221220s2022 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s40268-022-00395-2 |2 doi | |
| 035 | |a (DE-627)OLC207945725X | ||
| 035 | |a (DE-He213)s40268-022-00395-2-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 100 | 1 | |a Vella, Venanzio |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Correction: The Pitfalls of Abnormal Laboratory Value Interpretation in Vaccine Clinical Trials: The Example of Asymptomatic Transient Neutropenia |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © GSK 2022 | ||
| 700 | 1 | |a Schmidt, Johannes E. |4 aut | |
| 700 | 1 | |a Cilio, Giulia Luna |4 aut | |
| 700 | 1 | |a De Ryck, Iris |0 (orcid)0000-0003-3044-1117 |4 aut | |
| 700 | 1 | |a Podda, Audino |4 aut | |
| 700 | 1 | |a Conti, Valentino |0 (orcid)0000-0002-0416-952X |4 aut | |
| 700 | 1 | |a Auerbach, Joachim |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drugs in R & D |d Springer International Publishing, 1999 |g 22(2022), 3 vom: 22. Aug., Seite 253-253 |w (DE-627)320603598 |w (DE-600)2020476-0 |w (DE-576)435515438 |x 1174-5886 |7 nnns |
| 773 | 1 | 8 | |g volume:22 |g year:2022 |g number:3 |g day:22 |g month:08 |g pages:253-253 |
| 856 | 4 | 1 | |u https://doi.org/10.1007/s40268-022-00395-2 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OLC-DE-84 | ||
| 912 | |a SSG-OPC-PHA | ||
| 951 | |a AR | ||
| 952 | |d 22 |j 2022 |e 3 |b 22 |c 08 |h 253-253 | ||